Company intelligence / Profile preview

VintaBio

Philadelphia, Pennsylvania, United Statesvintabio.com ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

No direct clinical results as the company does not develop its own therapeutics. However, the team has supported over 50 clinical and commercial cell & gene therapy programs and contributed to three marketed products and over twenty BLA filings through their expertise.

Modalities: Viral vectors (Adeno-associated virus [AAV], Lentiviral vectors)Plasmids (manufacturing services)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on VintaBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VintaBio.

Explore the full profile